Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

90 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient-Reported Burden of Indolent Systemic Mastocytosis in a Managed Care Organization.
Zeiger RS, Tse KY, Li Q, Saparudin M, Al-Salman SS, Puttock EJ, Miller K, Powell D, Lampson B, Sullivan E, Chen W. Zeiger RS, et al. Among authors: tse ky. J Allergy Clin Immunol Pract. 2025 Jan;13(1):202-212.e7. doi: 10.1016/j.jaip.2024.10.021. Epub 2024 Oct 28. J Allergy Clin Immunol Pract. 2025. PMID: 39477015 Free article.
MASTering systemic mastocytosis: Lessons learned from a large patient cohort.
Tse KY, Chen W, Puttock EJ, Chowdhury S, Miller K, Powell D, Lampson B, Yuen C, Cattie D, Green T, Sullivan E, Zeiger RS. Tse KY, et al. J Allergy Clin Immunol Glob. 2024 Jul 27;3(4):100316. doi: 10.1016/j.jacig.2024.100316. eCollection 2024 Nov. J Allergy Clin Immunol Glob. 2024. PMID: 39234417 Free PMC article.
Phase II randomized study of dostarlimab alone or with bevacizumab versus non-platinum chemotherapy in recurrent gynecological clear cell carcinoma (DOVE/APGOT-OV7/ENGOT-ov80).
Lee JY, Tan D, Ray-Coquard I, Lee JB, Kim BG, Van Nieuwenhuysen E, Huang RY, Tse KY, González-Martin A, Scott C, Hasegawa K, Wilkinson K, Yang EY, Lheureux S, Kristeleit R. Lee JY, et al. Among authors: tse ky. J Gynecol Oncol. 2024 Dec 16. doi: 10.3802/jgo.2025.36.e51. Online ahead of print. J Gynecol Oncol. 2024. PMID: 39710508 Free article.
Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer.
Santin AD, Corr BR, Spira A, Willmott L, Butrynski J, Tse KY, Patel J, Mekan S, Wu T, Lin KW, Kuo P, Dumbrava EE. Santin AD, et al. Among authors: tse ky. J Clin Oncol. 2024 Oct 10;42(29):3421-3429. doi: 10.1200/JCO.23.02767. Epub 2024 Jul 31. J Clin Oncol. 2024. PMID: 39083724 Free PMC article. Clinical Trial.
Inhibition of Aberrantly Overexpressed Polo-like Kinase 4 Is a Potential Effective Treatment for DNA Damage Repair-Deficient Uterine Leiomyosarcoma.
Lee HHY, Chow KL, Wong HS, Chong TY, Wong AST, Cheng GHW, Ko JMK, Siu HC, Yeung MCF, Huen MSY, Tse KY, Bray MR, Mak TW, Leung SY, Ip PPC. Lee HHY, et al. Among authors: tse ky. Clin Cancer Res. 2024 Sep 3;30(17):3904-3918. doi: 10.1158/1078-0432.CCR-23-3720. Clin Cancer Res. 2024. PMID: 38848043 Free PMC article.
90 results